Remodulin: profile and news

Drug firm United Therapeutics to make Durham's RTP its new home  May 9, 2006
Chamber of Commerce. The plant will produce a tablet form of the firm's Remodulin therapy, which is a hypertension treatment. The drug ... - Durham Herald Sun,

United Therapeutics moves on to ovarian cancer drug, new labs  Apr 27, 2006
United Therapeutics’ fortunes have been fueled by sales of Remodulin, which treats pulmonary arterial hypertension and which accounted for more than 90 ... - Business Gazette,

United Therapeutics Reports First Quarter 2006 Financial Results  May 2, 2006
...quarter of 2005. The increases in revenues and gross margins resulted primarily from growth in sales of Remodulin. Net income was ... - PR Newswire (press release),

Accounting changes cut United Therapeutics profits  May 2, 2006
The company, whose drug Remodulin treats a rare form of lung disease, nearly doubled its research and development spending to $14.7 million as it works to ... - Washington Business Journal,